Skeletal Stem Cells: Lectins bring benefits to bones
- Stanford University, United States
Lectins are a diverse group of proteins that are attracted to carbohydrates and biomolecules that contain carbohydrate groups, including varieties of sugars and sugar-modified proteins and lipids. This attraction, which is highly specific, allows lectins to influence a wide range of biological processes. For example, many bacterial and mammalian lectins control how cells move and adhere to each other (Ghazarian et al., 2011), while some plant lectins, notably ricin and abrin, are renowned for their lethality (Olsnes, 2004).
A widely studied group of mammalian lectins are the c-type lectins, which are so named because they require a calcium ion to work correctly. Examples of c-type lectins include thrombomodulin, which regulates platelet-dependent coagulation, and selectins, which control the movement of white blood cells during inflammation (Cummings et al., 2009). Now, in eLife, Rui Yue, Bo Shen and Sean Morrison at the University of Texas Southwestern Medical Center report that Clec11a, a type of c-lectin that is expressed at high levels by cells in bone marrow, stimulates bone regeneration (Yue et al., 2016).
Since other types of lectins are known to help white blood cells interact with other cells, Yue et al. initially expected that Clec11a might regulate how new blood cells form in the bone marrow. To test this hypothesis, they generated knockout mice that lacked Clec11a. However, the effects of this deficiency were unexpectedly mild. The knockout mice developed normally and young adults were not significantly anatomically different from wild-type mice. The knockouts also had normal levels of hematopoietic stem cells, and these developed into mature blood cells at a normal rate.
About the only detectable difference exhibited by the knockout mice was a reduction in overall bone volume. This deficit increased over time and by 16 months of age, knockout mice had just over half the volume of bone of the wild-type mice. Further analysis revealed that the bone-mineral density of the knockout mice was also normal. However, significant age-related thinning of cortical bone (the hard outer layer along long bones) was observed in the knockout mice. Moreover, these mice also had a dramatically reduced ability to form trabecular bone (the “spongy” bone found near joints and in vertebrae).
Normal bone tissue undergoes continuous remodeling. Cells called osteoclasts destroy old bone, while cells called osteoblasts are involved in the formation of new bone (Figure 1). Therefore, it is possible that the loss of bone seen in the knockout mice is due to increased osteoclast activity. Indeed it is known that another type of lectin, galectin8, can increase RANKL signaling, which stimulates hematopoietic stem cells to develop into osteoclasts, hence increasing the rate at which bone is destroyed (Vinik et al., 2015). However, Yue et al. found that osteoclast numbers were not affected in knockout mice, raising the possibility that Clec11a is instead important for bone formation.
Figure 1
Lectin’s role in bone remodeling.
In adults, bones are maintained through the destruction of old bone by cells called osteoclasts (pink), and replenished through the activity of cells called osteoblasts (yellow-brown). Hematopoietic stem cells (HSC; purple) develop through a number of intermediate cell types to become mature osteoclasts, while skeletal stem cells (SSCs; green) can develop into a number of mature cell types, including chondrocytes, stromal cells and osteoblasts. The latter produce a c-type lectin called Clec11a that stimulates the formation of osteoblast progenitors from SSCs. (The WNT, VEGF, BMP and Hedgehog signaling pathways are also involved in this process.) The osteoblasts also produce a signaling protein called RANKL that stimulates the final stage of osteoclast development; another lectin called galectin8 encourages RANKL signaling. Currently, most treatments for osteoporosis interrupt RANKL signaling using compounds such as denosumab and bisphosphonates. The results presented by Yue et al. suggest that increasing the levels of Clec11a may form part of an alternative osteoporosis treatment.
By taking advantage of recent studies that characterized skeletal stem cell lineages in mice, Yue et al. next investigated whether Clec11a deficiency affects the skeletal stem or progenitor cells that may develop into osteoblasts (Bianco and Robey, 2015; Chan et al., 2015; Marecic et al., 2015; Worthley et al., 2015; Zhou et al., 2014; Méndez-Ferrer et al., 2010; Chan et al., 2009). Using a variety of techniques including fluorescence-activated cell sorting (FACS) analysis, they found that the knockout mice had a relatively normal number of skeletal stem cells: however, these cells were much less likely to develop into osteoblasts. In vitro studies performed with a recombinant form of the Clec11a protein show that Clec11a directly promotes the formation of osteoblasts from skeletal progenitor cells. Further experiments revealed that injections of Clec11a could fully restore the bone deficiencies seen in both Clec11a knockout mice and mice that displayed the symptoms of osteoporosis. Clec11a also stimulated human skeletal progenitor cells that had been implanted into mice to form bone. Taken together, these results indicate that Clec11a is essential for maintaining the integrity of the skeleton in adults.
From a clinical perspective, these findings are especially significant given the medical burden that osteoporosis and other age-related skeletal disorders pose to the aging global population. Treatment options for these conditions are limited and typically rely on agents such as bisphosphonates and RANKL antagonists that reduce osteoclast activity. However, these treatments are plagued by significant side effects, in part because they work in a non-specific manner (Gennari et al., 2016). Clec11a seems to act specifically at the point where skeletal stem and progenitor cells commit to developing into osteoblasts, and does not appear to affect other cell lineages that develop from the skeletal stem cells. Therefore, Yue et al. have demonstrated the potential of Clec11a to form part of a precise and targeted therapy for treating bone and bone-healing deficiencies.
In future, it will be important to determine how Clec11a works mechanistically at the molecular level. Focusing on purified skeletal stem cells and the progenitor cell lineages that they develop into could reveal whether Clec11a signaling intersects with other signaling pathways that are known to be involved in the formation of the skeleton, or whether it represents an entirely new signaling mechanism (Chan et al., 2015).
References
-
Essentials of GlycobiologyC-type lectins, Essentials of Glycobiology, 2nd edn, Cold Spring Harbor (NY), Cold Spring Harbor Laboratory Press, 20301263.
-
Treatment needs and current options for postmenopausal osteoporosisExpert Opinion on Pharmacotherapy 17:1141–1152.https://doi.org/10.1080/14656566.2016.1176147
Article and author information
Author details
Publication history
Copyright
© 2016, Chan et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,352
- views
-
- 157
- downloads
-
- 4
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Skeletal Stem Cells: Lectins bring benefits to bones
eLife 5:e22926.
https://doi.org/10.7554/eLife.22926
Further reading
-
- Developmental Biology
The intricate coordination of the neural network in planarian growth and regeneration has remained largely unrevealed, partly due to the challenges of imaging the CNS in three dimensions (3D) with high resolution and within a reasonable timeframe. To address this gap in systematic imaging of the CNS in planarians, we adopted high-resolution, nanoscale imaging by combining tissue expansion and tiling light-sheet microscopy, achieving up to fourfold linear expansion. Using an automatic 3D cell segmentation pipeline, we quantitatively profiled neurons and muscle fibers at the single-cell level in over 400 wild-type planarians during homeostasis and regeneration. We validated previous observations of neuronal cell number changes and muscle fiber distribution. We found that the increase in neuron cell number tends to lag behind the rapid expansion of somatic cells during the later phase of homeostasis. By imaging the planarian with up to 120 nm resolution, we also observed distinct muscle distribution patterns at the anterior and posterior poles. Furthermore, we investigated the effects of β-catenin-1 RNAi on muscle fiber distribution at the posterior pole, consistent with changes in anterior-posterior polarity. The glial cells were observed to be close in contact with dorsal-ventral muscle fibers. Finally, we observed disruptions in neural-muscular networks in inr-1 RNAi planarians. These findings provide insights into the detailed structure and potential functions of the neural-muscular system in planarians and highlight the accessibility of our imaging tool in unraveling the biological functions underlying their diverse phenotypes and behaviors.
-
- Developmental Biology
- Genetics and Genomics
Asthenoteratozoospermia, a prevalent cause of male infertility, lacks a well-defined etiology. DNAH12 is a special dynein featured by the absence of a microtubule-binding domain, however, its functions in spermatogenesis remain largely unknown. Through comprehensive genetic analyses involving whole-exome sequencing and subsequent Sanger sequencing on infertile patients and fertile controls from six distinct families, we unveiled six biallelic mutations in DNAH12 that co-segregate recessively with male infertility in the studied families. Transmission electron microscopy (TEM) revealed pronounced axonemal abnormalities, including inner dynein arms (IDAs) impairment and central pair (CP) loss in sperm flagella of the patients. Mouse models (Dnah12-/- and Dnah12mut/mut) were generated and recapitulated the reproductive defects in the patients. Noteworthy, DNAH12 deficiency did not show effects on cilium organization and function. Mechanistically, DNAH12 was confirmed to interact with two other IDA components DNALI1 and DNAH1, while disruption of DNAH12 leads to failed recruitment of DNALI1 and DNAH1 to IDAs and compromised sperm development. Furthermore, DNAH12 also interacts with radial spoke head proteins RSPH1, RSPH9, and DNAJB13 to regulate CP stability. Moreover, the infertility of Dnah12-/- mice could be overcome by intracytoplasmic sperm injection (ICSI) treatment. Collectively, DNAH12 plays a crucial role in the proper organization of axoneme in sperm flagella, but not cilia, by recruiting DNAH1 and DNALI1 in both humans and mice. These findings expand our comprehension of dynein component assembly in flagella and cilia and provide a valuable marker for genetic counseling and diagnosis of asthenoteratozoospermia in clinical practice.
